LAST WORD: Treatments for Hereditary Angioedema

LAST WORD: Treatments for Hereditary Angioedema

On August 24, 2021, ICER released a revised version of a final evidence report from 2018 evaluating the clinical and cost effectiveness of three emerging treatments for hereditary angioedema. Unfortunately, while ICER tried to update its analysis — supposedly to...
LAST WORD: Treatments for Atopic Dermatitis

LAST WORD: Treatments for Atopic Dermatitis

On August 17, 2021, ICER issued a Final Evidence Report on the clinical and cost-effectiveness of new treatments for atopic dermatitis (more commonly referred to as eczema). After following its typical process for gathering and reviewing data, ICER concluded that the...